港股異動丨固生堂(2273.HK)再度漲超8%續刷新高價 10個交易日股價翻倍
格隆匯1月4日丨固生堂(2273.HK)延續強勢上漲行情,大幅拉昇漲8.4%,最高報49.55港元再創歷史新高,10個交易日股價翻倍,總市值超110億港元。公司中醫師數量、線下醫療機構數量,及線下機構城市覆蓋數量均為行業第一。中信證券首予固生堂買入評級,料固生堂在2021至2023年核心淨利潤分別為1.5億、2.25億及3.26億元。近年中醫藥行業鼓勵政策頻頻出台,中醫藥產業已經發展成為內地醫療健康行業的重要組成部分。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.